— Who We Are

We exist to help more donated organs reach the patients who need them. 

We're not just improving transplantation.

We're rebuilding its operating system. 

Transplantation's greatest challenges are rooted in system constraints. Limited preservation time, fragmented workflows, and incomplete visibility during transport shape how organs are assessed, how teams coordinate, and ultimately whether a donated organ can be used with confidence. 

BMI OrganBank was founded to change that. We build the technologies and infrastructure that make transplantation a connected system — metabolically active preservation, real-time organ viability data, and coordination across the entire transplant journey. The future of transplantation depends not just on better devices, but on the systems that link them together. 

Our Values

We're inherently curious — always seeking knowledge and applying it for the benefit of patients and those who care for them.

We're creative and tenacious in the face of hard problems, and we learn as much from failure as from success.

We do what's right even when no one is watching, and especially when lives are at stake.

We never forget why we come to work, and we leave our egos in the parking lot. We focus on getting it right, not on being right.

Every team member takes pride in their work and holds themselves accountable to each other and to the patients counting on us.

Meet our leadership

Carrie DiMarzio

Co-Founder & CEO
Carrie DiMarzio has dedicated her career to creating a better future by using her leadership skills in tandem with her expertise in science and engineering.

David Gerber

Chief Medical Officer
Christian R. Holmes Professor of Surgery and Chair, Department of Surgery, University of Cincinnati College of Medicine

Andrew S. Barbas

Chief Science Officer
Board-certified Kidney/Pancreas Transplant Surgeon, Liver Transplant Surgeon, Pediatric Kidney Transplant Surgeon, Pediatric Liver Transplant Surgeon with Duke University Hospital

Paul Volovich

Chief Financial Officer
Seasoned executive with a strong record in finance, consulting, and investment. Leads financial strategy, capital planning, and operations.

Varun Kopparthy

Chief Technology Officer
13+ years of medical device development experience focusing on ex vivo organ preservation technology and point-of-care diagnostics.

Our Team

Risus velit condimentum vitae tincidunt tincidunt. Mauris ridiculus fusce amet urna nunc.

Keren Frederick

VP of Human Resources

Chip Aardema

Head of Perfusion

Ellie Cathleen Cohen

Operations Coordinator & Research Associate Engineer

Josh Copus

Research Engineer II

Tyler Adcock

Research Engineer

Carly Sison

Lead OBK Perfusionist

Scientific Advisors

David A. Axelrod

MD, MBA, FACS
Professor of Surgery with expertise in kidney, pancreas, and living donor transplantation, and a leader in clinical outcomes and transplant innovation.

Matthew Hartwig

MD DUKE
Associate Professor of Surgery, Duke University School of Medicine, Division Cardiovascular and Thoracic Surgery

Prabir Roy-Chaudhury

MD & Ph.D, FRCP UNC
Professor of Medicine, Division of Nephrology and Hypertension, Co-Director, UNC Kidney Center and leading transplant nephrologist

Board of Directors

George Barr

Board of Directors
Founder of Anatech Ltd., BioMedInnovations (now BMI OrganBank), and Industrial Hard Carbon, has dedicated over 40 years to advancing medical technology and innovative materials.

Carrie DiMarzio

Board of Directors
Carrie DiMarzio has dedicated her career to creating a better future by using her leadership skills in tandem with her expertise in science and engineering.

Elizabeth Faulkner Flanary

Board of Directors
Clinical RN III specializing in pediatric cardiac intensive care at Levine Children’s Hospital; former Best Practice Committee member for hospital-acquired infection prevention.

Paul Quadros

Board of Directors
BMI OrganBank Board of Directors, veteran life science venture capitalist and angel investor, serial entrepreneur with multiple exits.

The Technology Behind the Mission

See how the OrganBank platform is designed to change organ preservation, transport, and transplant coordination.
Explore the Platform →
Get in Touch →
Keeping more paths to transplant open.

PLATFORM & TECHNOLOGY

  • Platform Overview
  • Clinical Workflow
  • The Science
  • System Components

RESEARCH SERVICES

  • Ex-Vivo Institute
  • OrganBank Lab

CLINICAL EVIDENCE

  • Publications
  • Preclinical Validation
  • Data & Outcomes
  • Scientific Posters & Presentations

ABOUT

  • Our Story
  • Leadership
  • Consortium
  • Careers
  • Contact

NEWS & INSIGHTS

  • Company News
  • Featured Content
  • Resource Library
  • Newsletter

 

BMI OrganBank®
Wake Forest Institute of Regenerative Medicine
391 Technology Way | Winston-Salem, NC 27101 | USA

© 2026 BMI OrganBank. All rights reserved.
Privacy Policy Terms & Conditions

Blood-free perfusate

Proprietary acellular perfusate designed to support metabolically active preservation—enabling oxygen delivery, nutrient support, and management of oxidative stress without the need for donor-matched blood.

Real-time visibility across the journey

Tracks organ status and location during preservation and transport, supporting coordination and assessment across teams.

Portable perfusion. Continuous preservation.

Automated, portable device designed to maintain kidneys in a metabolically active state during preservation and transport.
Operates at room temperature without donor-matched blood.